Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients

Aloul, M. M.; Crawley, J.; Winstanley, C.; Hart, C. A.; Ledson, M. J.; Walshaw, M. J.
April 2004
Thorax;Apr2004, Vol. 59 Issue 4, p334
Academic Journal
Background: Chronic pulmonary infection with transmissible Pseudomonas aeruginosa strains in individuals with cystic fibrosis (CF) has been reported, raising issues of cross infection and patient segregation. The first such strain to be described (the Liverpool epidemic strain, LES) is now widespread in many UK CF centres. However, whether such infection carries a worse prognosis is unknown. To address this, the clinical course of a group of CF patients chronically infected by LES was compared with that in patients harbouring unique strains. Methods: Using P aeruginosa strain genotyping, two cohorts of CF patients attending the Liverpool CF service were identified who were LES positive or negative in 1998 and remained so until 2002. From these, two groups of 12 patients were matched in 1998 for age, spirometric parameters, and nutritional state and their clinical course was followed for 5 years. Patients chronically infected with Burkholderia cepacia were excluded. Results: Patients chronically infected with LES had a greater annual loss of lung function than those not chronically infected by LES (mean difference between groups -4.4% (95% CI -8.1 to -0.9; p<0.02)), and by 2002 their percentage predicted forced expiratory volume in 1 second (FEV1) was worse (mean 65.0% v 82.6%, p<0.03). Their nutritional state also deteriorated over the study period (mean difference between groups in body mass index -0.7 (95% Cl -1 .2 to -0.2; p<0.01 )), such that by 2002 they were malnourished compared with LES negative patients (mean BMI 19.4 v 22.7, p<0.02). Conclusions: Chronic infection with the Liverpool epidemic P aeruginosa strain in CF patients confers a worse prognosis than infection with unique strains alone, confirming the need for patient segregation. Since this strain is common in many CF units, strain identification in all CF centres is essential. This can only be carried out using genomic typing methods.


Related Articles

  • The Role of Sphingolipids and Ceramide in Pulmonary Inflammation in Cystic Fibrosis. Becker, Katrin Anne; Riethmüller, Joachim; Yang Zhang; Gulbins, Erich // Open Respiratory Medicine Journal;2010, Vol. 4, p39 

    Sphingolipids and in particular ceramide have been shown to be critically involved in the response to many receptor-mediated, but also receptor-independent, mainly stress stimuli. Recent studies demonstrate that ceramide plays an important role in the pathogenesis of cystic fibrosis, a...

  • Normal and Cystic Fibrosis Human Bronchial Epithelial Cells Infected with Pseudomonas aeruginosa Exhibit Distinct Gene Activation Patterns. Balloy, Viviane; Varet, Hugo; Dillies, Marie-Agnès; Proux, Caroline; Jagla, Bernd; Coppée, Jean-Yves; Tabary, Olivier; Corvol, Harriet; Chignard, Michel; Guillot, Loïc // PLoS ONE;10/20/2015, Vol. 10 Issue 10, p1 

    Background and Aims: In cystic fibrosis (CF), Pseudomonas aeruginosa is not eradicated from the lower respiratory tract and is associated with epithelial inflammation that eventually causes tissue damage. To identify the molecular determinants of an effective response to P. aeruginosa...

  • Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis. Duong, Jessica; Booth, Sean C.; McCartney, Nathan K.; Rabin, Harvey R.; Parkins, Michael D.; Storey, Douglas G. // PLoS ONE;11/23/2015, Vol. 10 Issue 11, p1 

    Epidemic strains of Pseudomonas aeruginosa have been found worldwide among the cystic fibrosis (CF) patient population. Using pulse-field gel electrophoresis, the Prairie Epidemic Strain (PES) has recently been found in one-third of patients attending the Calgary Adult CF Clinic in Canada. Using...

  • Association between Initial Disease Presentation, Lung Disease Outcomes, and Survival in Patients with Cystic Fibrosis. Lai, HuiChuan J.; Cheng, Yu; Cho, Hyungjun; Kosorok, Michael R.; Farrell, Philip M. // American Journal of Epidemiology;Mar2004, Vol. 159 Issue 6, p537 

    This US study was conducted to determine whether mode of diagnosis and initial disease presentation influence lung disease and survival in patients with cystic fibrosis. The study population included 27,703 patients reported to the 1986–2000 Cystic Fibrosis Foundation Registry. Patients...

  • The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages. Essoh, Christiane; Blouin, Yann; Loukou, Guillaume; Cablanmian, Arsher; Lathro, Serge; Kutter, Elizabeth; Thien, Hoang Vu; Vergnaud, Gilles; Pourcel, Christine // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Phage therapy may become a complement to antibiotics in the treatment of chronic Pseudomonas aeruginosa infection. To design efficient therapeutic cocktails, the genetic diversity of the species and the spectrum of susceptibility to bacteriophages must be investigated. Bacterial strains showing...

  • DPI antibacterials for P. aeruginosa in CF value for money?  // PharmacoEconomics & Outcomes News;Jan2014, Issue 694, p4 

    The article discusses research being done on the effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis, which references a study by P. Tappenden et al. published in the "December 13, 2013 issue of "PharmacoEconomics."

  • Gerimax Ginseng Regulates Both Humoral and Cellular Immunity During Chronic Pseudomonas aeruginosa Lung Infection. Song, Zhijun; Wu, Hong; Mathee, Kalai; Høiby, Niels; Kharazmi, Arsalan // Journal of Alternative & Complementary Medicine;Aug2002, Vol. 8 Issue 4, p459 

    Background: Chronic lung infection among patients with cystic fibrosis (CF), diffused panbronchiolitis, and chronic obstructive bronchiecteisis is often because of Pseudomonas aeruginosa. High morbidity and mortality in patients with CF are because of P. aeuruginosa that undergoes genotypic and...

  • Small-Colony Variants of Pseudomonas aeruginosa in Cystic Fibrosis. Häubetaler, Susanne; Tümmler, Burkhard; Wiebetabrodt, Hartmut; Rohde, Manfred; Steinmetz, Ivo // Clinical Infectious Diseases;9/1/1999, Vol. 29 Issue 3, p621 

    Investigates the presence of small-colony variants (SCV) of Pseudomonas aeruginosa (P. aeruginosa) in respiratory tract specimens from patients with cystic fibrosis (CF). Background information on cystic fibrosis and P. aeruginosa; Correlation of recovery of SCV with several parameters; Its...

  • A Critical New Pathway for Toxin Secretion? Yahr, Timothy L. // New England Journal of Medicine;9/14/2006, Vol. 355 Issue 11, p1171 

    The author focuses on the therapeutic targeting of critical pathways required for toxin secretion in the composition of vaccines. Five distinct protein secretion pathways are understood to contribute to the virulence of bacterial pathogens. Recently, a sixth secretion pathway has been identified...


Read the Article


Sign out of this library

Other Topics